Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Total Current Liabilities (2022 - 2025)

Envoy Medical's Total Current Liabilities history spans 4 years, with the latest figure at $11.6 million for Q4 2025.

  • Quarterly results put Total Current Liabilities at $11.6 million for Q4 2025, up 53.38% from a year ago — trailing twelve months through Dec 2025 was $11.6 million (up 53.38% YoY), and the annual figure for FY2025 was $11.6 million, up 53.38%.
  • Total Current Liabilities for Q4 2025 was $11.6 million at Envoy Medical, up from $9.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $12.7 million in Q3 2023 to a low of $2.5 million in Q4 2022.
  • The 4-year median for Total Current Liabilities is $7.8 million (2025), against an average of $7.8 million.
  • The sharpest move saw Total Current Liabilities soared 189.2% in 2023, then dropped 28.49% in 2024.
  • Year by year, Total Current Liabilities stood at $2.5 million in 2022, then soared by 189.2% to $7.3 million in 2023, then grew by 3.47% to $7.5 million in 2024, then skyrocketed by 53.38% to $11.6 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $11.6 million, $9.0 million, and $8.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.